{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T12:05:18Z","timestamp":1743941118648},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1007\/s00105-006-1273-x","type":"journal-article","created":{"date-parts":[[2007,1,11]],"date-time":"2007-01-11T08:58:44Z","timestamp":1168505924000},"page":"122-127","source":"Crossref","is-referenced-by-count":4,"title":["Anti-Interleukin-5-Therapie bei eosinophilen Erkrankungen"],"prefix":"10.1007","volume":"58","author":[{"given":"D.","family":"Simon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.R.","family":"Braathen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-U.","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1273_CR1","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1046\/j.1523-1747.1999.00720.x","volume":"113","author":"Akdis","year":"1999","unstructured":"Akdis CA, Akdis M, Simon D et al. (1999) T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J Invest Dermatol 113: 628\u2013634","journal-title":"J Invest Dermatol"},{"key":"1273_CR2","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1542-3565(04)00236-8","volume":"2","author":"Arora","year":"2004","unstructured":"Arora AS, Yamazaki K (2004) Eosinophilic esophagitis: asthma of the esophagus. Clin Gastroenterol Hepatol 2: 523\u2013530","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1273_CR3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1183\/09031936.03.00027302","volume":"21","author":"Buttner","year":"2003","unstructured":"Buttner C, Lun A, Splettstoesser T et al. (2003) Monoclonal anti-interleukin-5 treatment suppresses eosinophil but not T-cell functions. Eur Respir J 21: 799\u2013803","journal-title":"Eur Respir J"},{"key":"1273_CR4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0091-6749(97)70031-9","volume":"99","author":"Cheng","year":"1997","unstructured":"Cheng JF, Ott NL, Peterson EA et al. (1997) Dermal eosinophils undergo cytolytic degeneration. J Allergy Clin Immunol 99: 683\u2013692","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR5","doi-asserted-by":"crossref","unstructured":"Chusid MJ, Dale DC, West BC, Wolff SM (1975) The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54: 1\u201327","DOI":"10.1097\/00005792-197501000-00001"},{"key":"1273_CR6","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1164\/rccm.200208-789OC","volume":"167","author":"Flood-Page","year":"2003","unstructured":"Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS (2003) Eosinophil\u2019s role remains uncertain as anti-IL-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 167: 199\u2013204","journal-title":"Am J Respir Crit Care Med"},{"key":"1273_CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jaci.2003.10.049","volume":"113","author":"Garrett","year":"2004","unstructured":"Garrett JK, Jameson SC, Thomson B et al. (2004) Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes. J Allergy Clin Immunol 113: 115\u2013119","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR8","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","volume":"118","author":"Geveart","year":"2006","unstructured":"Geveart P, Lang-Loidolt D, Lackner A et al. (2006) Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118: 1133\u20131141","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR9","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1067\/mai.2000.105712","volume":"105","author":"Gleich","year":"2000","unstructured":"Gleich GJ (2000) Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 105: 651\u2013663","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR10","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.170.11.5359","volume":"170","author":"Gregory","year":"2003","unstructured":"Gregory B, Kirchem A, Phipps S et al. (2003) Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor \u03b1-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor \u03b1 expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor \u03b1 expression. J Immunol 170: 5359\u20135366","journal-title":"J Immunol"},{"key":"1273_CR11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1034\/j.1600-065X.2001.790118.x","volume":"179","author":"Hamelman","year":"2001","unstructured":"Hamelman E, Gelfand EW (2001) IL-5-induced airway eosinophilia-the key to asthma? Immunol Rev 179: 182\u2013191","journal-title":"Immunol Rev"},{"key":"1273_CR12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1067\/mai.2001.116576","volume":"108","author":"Hart","year":"2001","unstructured":"Hart TK, Cook RM, Zia-Amirhosseini P et al. (2001) Preclinical efficacy and safety of mepolizumab (SB-240563), a humanized monoclonal antibody to IL-5, in cynomolgus monkeys. J Allergy Clin Immunol 108: 250\u2013257","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR13","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1046\/j.1365-2133.2001.04456.x","volume":"145","author":"Kiehl","year":"2001","unstructured":"Kiehl P, Falkenberg K, Vogelbruch M, Kapp A (2001) Tissue eosinophilia in acute and chronic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 145: 720\u2013729","journal-title":"Br J Dermatol"},{"key":"1273_CR14","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1164\/rccm.200206-525OC","volume":"167","author":"Kips","year":"2003","unstructured":"Kips JC, O\u2019Connor BJ, Langley SJ et al. (2003) Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistant asthma: a pilot study. Am J Respir Crit Care Med 167: 1655\u20131659","journal-title":"Am J Respir Crit Care Med"},{"key":"1273_CR15","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaci.2003.10.050","volume":"113","author":"Klion","year":"2004","unstructured":"Klion A, Nutman TB (2004) The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 113: 30\u201337","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR16","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/S0140-6736(00)03496-6","volume":"356","author":"Leckie","year":"2000","unstructured":"Leckie MJ, ten Brinke A, Khan J et al. (2000) Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 356: 2144\u20132148","journal-title":"Lancet"},{"key":"1273_CR17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1056\/NEJM198508013130502","volume":"313","author":"Leifermann","year":"1985","unstructured":"Leifermann KM, Ackermann SJ, Sampson HA et al. (1985) Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis: comparison with onchocerciasis. N Engl J Med 313: 282\u2013285","journal-title":"N Engl J Med"},{"key":"1273_CR18","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1084\/jem.20020009","volume":"195","author":"Mattes","year":"2002","unstructured":"Mattes J, Yang M, Mahalingam S et al. (2002) Intrinsic defect in T cell production of interleukin (IL)-13 in the abscence of both IL-5 and eotaxin precludes the development of eosinophilia and airway hyperreactivity in experimental asthma. J Exp Med 195: 1433\u20131444","journal-title":"J Exp Med"},{"key":"1273_CR19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mai.2003.1382","volume":"111","author":"Menzies-Gow","year":"2003","unstructured":"Menzies-Gow A, Flood-Page P, Sehmai R et al. (2003) Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics. J Allergy Clin Immunol 111: 714\u2013719","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.gastro.2003.07.007","volume":"125","author":"Mishra","year":"2003","unstructured":"Mishra A, Rothenberg ME (2003) Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent manner. Gastroenterology 125: 1419\u20131427","journal-title":"Gastroenterology"},{"key":"1273_CR21","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1398-9995.2005.00791.x","volume":"60","author":"Oldhoff","year":"2005","unstructured":"Oldhoff JM, Darsow U, Werfel T et al. (2005) Anti-IL-5 recombinant humanized monoclonal antibody (Mepolizumab) for the treatment of atopic dermatitis. Allergy 60: 693\u2013696","journal-title":"Allergy"},{"key":"1273_CR22","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.0022-202X.2004.22619.x","volume":"122","author":"Phipps","year":"2004","unstructured":"Phipps S, Flood-Page P, Menzies-Gow A et al. (2004) Intravenous anti-IL-5 monoclonal antibody reduces eosinophils and tenascin deposition in allergen-challenged human atopic skin. J Invest Dermatol 122: 1406\u20131412","journal-title":"J Invest Dermatol"},{"key":"1273_CR23","first-page":"2332","volume":"349","author":"Pl","year":"2003","unstructured":"Pl\u00f6tz SG, Simon HU, Darsow U, Simon D, Vassina E, Yousefi S, Hein R, Smith T, Behrendt H, Ring J (2003) Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349:2332\u20132337.","journal-title":"N Engl J Med"},{"key":"1273_CR24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1398-9995.2004.00476.x","volume":"59","author":"Simon","year":"2004","unstructured":"Simon D, Braathen LR, Simon HU (2004) Eosinophils and atopic dermatitis. Allergy 59: 561\u2013570","journal-title":"Allergy"},{"key":"1273_CR25","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jaci.2004.05.066","volume":"114","author":"Simon","year":"2004","unstructured":"Simon D, Vassina E, Yousefi S et al. (2004) Reduced dermal infiltration of cytokine-expressing cells in atopic dermatitis following short-term topical tacrolimus treatment. J Allergy Clin Immunol 114: 887\u2013895","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR26","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1398-9995.2005.00798.x","volume":"60","author":"Simon","year":"2005","unstructured":"Simon D, Vassina E, Yousefi S et al. (2005) Inflammatory cell numbers and cytokine expression in atopic dermatitis after topical pimecrolimus treatment. Allergy 60: 944\u2013951","journal-title":"Allergy"},{"key":"1273_CR27","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jaci.2005.01.017","volume":"115","author":"Simon","year":"2005","unstructured":"Simon D, Marti H, Heer P et al. (2005) Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases. J Allergy Clin Immunol 115: 1090\u20131092","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR28","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1046\/j.1365-2222.1998.00415.x","volume":"28","author":"Simon","year":"1998","unstructured":"Simon HU (1998) Eosinophil apoptosis in allergic diseases \u2013 an emerging new issue. Clin Exp Allergy 28: 1321\u20131324","journal-title":"Clin Exp Allergy"},{"key":"1273_CR29","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","volume":"341","author":"Simon","year":"1999","unstructured":"Simon HU, Pl\u00f6tz SG, Dummer R, Blaser K (1999) Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341: 1112\u20131120","journal-title":"N Engl J Med"},{"key":"1273_CR30","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1067\/mai.2001.119917","volume":"108","author":"Straumann","year":"2001","unstructured":"Straumann A, Bauer M, Fischer B et al. (2001) Idiopathic eosinophilic esophagitis is associated with a T(H)2-type allergic inflammatory response. J Allergy Clin Immunol 108: 954\u2013961","journal-title":"J Allergy Clin Immunol"},{"key":"1273_CR31","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1053\/j.gastro.2003.09.024","volume":"125","author":"Straumann","year":"2003","unstructured":"Straumann A, Spichtin HP, Grize L et al. (2003) Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years. Gastroenterology 125: 1660\u20131669","journal-title":"Gastroenterology"},{"key":"1273_CR32","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1046\/j.1398-9995.2003.00382.x","volume":"59","author":"Straumann","year":"2004","unstructured":"Straumann A, Simon HU (2004) The physiological and pathophysiological roles of eosinophils in the gastrointestinal tract. Allergy 59: 15\u201325","journal-title":"Allergy"},{"key":"1273_CR33","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1172\/JCI2686","volume":"102","author":"Wang","year":"1998","unstructured":"Wang J, Palmer K, L\u00f6tvall J et al. (1998) Circulating, but not local lung, IL-5 is required for the development of antigen-induced airway eosinophilia. J Clin Invest 102: 1132\u20131141","journal-title":"J Clin Invest"},{"key":"1273_CR34","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1093\/intimm\/11.12.1935","volume":"11","author":"Zhang","year":"1999","unstructured":"Zhang J, Kuvelkar R, Murgolo NJ et al. (1999) Mapping and characterization of the epitope(s) of Sch 55700, a humanized mAb, that inhibits human IL-5. Int Immunol 11: 1935\u20131944","journal-title":"Int Immunol"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1273-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-006-1273-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-006-1273-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:14Z","timestamp":1558568234000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-006-1273-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["1273"],"URL":"https:\/\/doi.org\/10.1007\/s00105-006-1273-x","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}